drugset / Trial / NCT02304107

Comparison Between Letrozole and Urinary Purified FSH in Women With Clomiphene Citrate Resistant Polycystic Ovarian Syndrome.

NCT02304107

Phase 3 Completed 140 enrolled Cairo University
RandomizedParallel-groupOpen-labelTreatment

Summary

210 women with clomiphene resistant PCOS will be randomly divided into 3 equal groups using computer generated random numbers. Group 1 will receive FSH, group 2 will have Letrozole and group 3 will act as the control group with no intervention.

Timeline

Start
2013-05
Primary completion
2015-01
Completion
2015-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bravelle Unknown 75 iu
Comparator Letrozole Other / unclassified 2.5 mg Oral

Indications